BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dewanjee S, Kandimalla R, Kalra RS, Valupadas C, Vallamkondu J, Kolli V, Dey Ray S, Reddy AP, Reddy PH. COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges. Cells 2021;10:3291. [PMID: 34943795 DOI: 10.3390/cells10123291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Krenytska D, Kot L, Halenova T, Raksha N, Vovk T, Savchuk O, Pellicano R, Abenavoli L, Falalyeyeva T, Ostapchenko L. Cytokine profile in patients with osteoarthritis after SARS-CoV-2 infection. Minerva Biotechnol Biomol Res 2022;34. [DOI: 10.23736/s2724-542x.22.02943-1] [Reference Citation Analysis]
2 Maraia Z, Mazzoni T, Rocchi MBL, Feliciani D, Romani MC, Acciarri G, Rafaiani S, Mazzoni I. Anti-TNFα Drugs and Interleukin Inhibitors: Epidemiological and Pharmacovigilance Investigation in COVID-19 Positive Patients. JPM 2022;12:1770. [DOI: 10.3390/jpm12111770] [Reference Citation Analysis]
3 Mekky RY, Elemam NM, Eltahtawy O, Zeinelabdeen Y, Youness RA. Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin–Drug Interactions Exist? Life 2022;12:1654. [DOI: 10.3390/life12101654] [Reference Citation Analysis]
4 Roseti L, Grigolo B. COVID-19 and rheumatic diseases: A mini-review. Front Med 2022;9. [DOI: 10.3389/fmed.2022.997876] [Reference Citation Analysis]
5 Zheng Q, Wang D, Lin R, Lv Q, Wang W. IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. Front Immunol 2022;13:1013322. [DOI: 10.3389/fimmu.2022.1013322] [Reference Citation Analysis]
6 Kudryavtsev IV, Golovkin AS, Totolian AA. T helper cell subsets and related target cells in acute COVID-19. Russian Journal of Infection and Immunity 2022;12:409-26. [DOI: 10.15789/2220-7619-thc-1882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yao M, Huang X, Guo Y, Zhao JV, Liu Z. Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID-19 outcomes: genome-wide cross trait analysis and bi-directional Mendelian randomization study.. [DOI: 10.1101/2022.06.10.22276268] [Reference Citation Analysis]
8 Pires RE, Reis IGN, Waldolato GS, Pires DD, Bidolegui F, Giordano V. What Do We Need to Know About Musculoskeletal Manifestations of COVID-19?: A Systematic Review. JBJS Rev 2022;10. [PMID: 35658089 DOI: 10.2106/JBJS.RVW.22.00013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sorotskaya VN, Plakhova AO, Halmuradova BB, Vaisman DS, Balabanova RM. Effect of COVID-19 coronavirus infection on the course of rheumatoid arthritis. Naučno-praktičeskaâ revmatologiâ 2022;60:157-161. [DOI: 10.47360/1995-4484-2022-157-161] [Reference Citation Analysis]
10 Savchenko AA, Tikhonova E, Kudryavtsev I, Kudlay D, Korsunsky I, Beleniuk V, Borisov A. TREC/KREC Levels and T and B Lymphocyte Subpopulations in COVID-19 Patients at Different Stages of the Disease. Viruses 2022;14:646. [PMID: 35337053 DOI: 10.3390/v14030646] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]